0000009326-26-000007
SEC filingBalchem Corporation reported strong financial performance for fiscal year 2025, with net sales of $1.04 billion and net earnings of $154.8 million. The company generated a gross margin of $370.6 million (35.6% gross margin) and operating income of $209.3 million (20.1% operating margin). Cash flow from operations was robust at $216.6 million, significantly exceeding net earnings. The company maintained a solid balance sheet with total assets of $1.69 billion, total liabilities of $428.8 million, and stockholders' equity of $1.26 billion. Key activities included $43.5 million in capital expenditures, $107.6 million in stock repurchases, and $28.3 million in dividends paid. The company ended the year with $66.6 million in cash and cash equivalents. Earnings per share were $5.00 both basic and diluted.
Balchem Corporation reported fiscal year 2025 results with net sales of $1.04 billion and net earnings of $154.8 million. The company achieved a gross margin of $370.6 million (35.6% gross margin) and operating income of $209.3 million (20.1% operating margin). Earnings per share were $5.00 both basic and diluted. Cash flow from operations was $216.6 million, significantly exceeding net earnings. The company invested $43.5 million in capital expenditures and intangible assets, repurchased $107.6 million of common stock, and paid $28.3 million in dividends. Total assets were $1.69 billion with stockholders' equity of $1.26 billion.
No segment revenue breakdown or geographic mix data was provided in the available financial data. The company reported consolidated net sales of $1.04 billion for the fiscal year ending December 31, 2025. No specific growth drivers or segment performance details were disclosed in the provided financial statements.
The company maintained healthy profitability with a gross margin of 35.6% ($370.6 million gross profit on $1.04 billion sales). Operating expenses totaled $161.3 million, consisting of selling expenses ($75.4 million), research and development ($18.5 million), and general and administrative expenses ($67.4 million). This resulted in an operating margin of 20.1% ($209.3 million operating income). After interest expense of $10.2 million and income tax expense of $44.2 million, net earnings were $154.8 million.
Operating cash flow was strong at $216.6 million, driven by net earnings of $154.8 million plus adjustments including depreciation and amortization of $45.7 million. Investing activities used $43.9 million primarily for capital expenditures. Financing activities used $152.8 million for debt repayments, stock repurchases, and dividends. Free cash flow (operating cash flow minus capital expenditures) was $172.7 million. The balance sheet shows total assets of $1.69 billion including $816.4 million in goodwill. Total liabilities were $428.8 million including $164.0 million in revolving loan debt. The current ratio (current assets/current liabilities) was 2.07.
No management guidance, strategic priorities, or specific risk factors were provided in the available financial data. The filing contains standard financial statements without forward-looking statements or outlook commentary in the provided sections.